skip to main content


Title: Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA‐Sequencing
Objective

To obtain the comprehensive transcriptome profile of human citrulline‐specific B cells from patients with rheumatoid arthritis (RA).

Methods

Citrulline‐ and hemagglutinin‐specific B cells were sorted by flow cytometry using peptide–streptavidin conjugates from the peripheral blood ofRApatients and healthy individuals. The transcriptome profile of the sorted cells was obtained byRNA‐sequencing, and expression of key protein molecules was evaluated by aptamer‐basedSOMAscan assay and flow cytometry. The ability of these proteins to effect differentiation of osteoclasts and proliferation and migration of synoviocytes was examined by in vitro functional assays.

Results

Citrulline‐specific B cells, in comparison to citrulline‐negative B cells, from patients withRAdifferentially expressed the interleukin‐15 receptor α (IL‐15Rα) gene as well as genes related to protein citrullination and cyclicAMPsignaling. In analyses of an independent cohort of cyclic citrullinated peptide–seropositiveRApatients, the expression ofIL‐15Rα protein was enriched in citrulline‐specific B cells from the patients’ peripheral blood, and surprisingly, all B cells fromRApatients were capable of producing the epidermal growth factor ligand amphiregulin (AREG). Production ofAREGdirectly led to increased migration and proliferation of fibroblast‐like synoviocytes, and, in combination with anti–citrullinated protein antibodies, led to the increased differentiation of osteoclasts.

Conclusion

To the best of our knowledge, this is the first study to document the whole transcriptome profile of autoreactive B cells in any autoimmune disease. These data identify several genes and pathways that may be targeted by repurposing severalUSFood and Drug Administration–approved drugs, and could serve as the foundation for the comparative assessment of B cell profiles in other autoimmune diseases.

 
more » « less
Award ID(s):
1705464
NSF-PAR ID:
10460996
Author(s) / Creator(s):
 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  
Publisher / Repository:
Wiley Blackwell (John Wiley & Sons)
Date Published:
Journal Name:
Arthritis & Rheumatology
Volume:
71
Issue:
4
ISSN:
2326-5191
Page Range / eLocation ID:
p. 529-541
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Summary

    Cytoskeletal microtubules (MTs) have a multitude of functions including intracellular distribution of molecules and organelles, cell morphogenesis, as well as segregation of the genetic material and separation of the cytoplasm during cell division among eukaryotic organisms. In response to internal and external cues, eukaryotic cells remodel theirMTnetwork in a regulated manner in order to assemble physiologically important arrays for cell growth, cell proliferation, or for cells to cope with biotic or abiotic stresses. Nucleation of newMTs is a critical step forMTremodeling. Although many key factors contributing toMTnucleation and organization are well conserved in different kingdoms, the centrosome, representing the most prominent microtubule organizing centers (MTOCs), disappeared during plant evolution as angiosperms lack the structure. Instead, flexibleMTOCs may emerge on the plasma membrane, the nuclear envelope, and even organelles depending on types of cells and organisms and/or physiological conditions.MT‐dependentMTnucleation is particularly noticeable in plant cells because it accounts for the primary source ofMTgeneration for assembling spindle, phragmoplast, and cortical arrays when the γ‐tubulin ring complex is anchored and activated by the augmin complex. It is intriguing what proteins are associated with plant‐specificMTOCs and how plant cells activate or inactivateMTnucleation activities in spatiotemporally regulated manners.

     
    more » « less
  2. Summary

    Signalling events downstream the B‐cell receptor (BCR) are central for the survival and progression of chronic lymphocytic leukaemia (CLL) cells. Focal adhesion kinase (FAK), regulated through calpain, interacts with molecules ofBCRsignalling, cytoskeletal modelling and disease progression, such as Src/Lyn, cortactin andHS1. Hypothesizing thatFAKmight play a key role inCLLpathogenesis, we observed a down‐modulation ofFAKwhole form, associated withFAKcleavage due to calpain activity uponBCRstimulation. Patients, whose cells were able to release Ca++afterBCRstimulation, had less amount of full‐lengthFAK, which translated into a higher presence of cleaved/activated form of the protein phosphorylated atY397, these features being mostly shown by immunoglobulin heavy chain (IGHV)‐unmutated poor‐prognosis patients. Moreover, we found that cortactin andHS1proteins were overexpressed in those cells, suggesting a possible interplay withFAK. Treatment with theFAKinhibitor Defactinib was able to induce apoptosis inCLLcells. In conclusion, the malignant phenotype in unfavourable‐prognosis patients seems to be encouraged by the overexpression of cortactin andHS1, that, together withFAK, may be involved in a druggable pathogenetic pathway inCLL.

     
    more » « less
  3. Summary

    Phagocytosis, macropinocytosis and antigen presentation by dendritic cells (DC) requires reorganization of the actin cytoskeleton. Drebrin (Dbn1) is an actin binding and stabilizing protein with roles in endocytosis, formation of dendrite spines in neurons and coordinating cell–cell synapses in immune cells. However, its role inDCphagocytosis and antigen presentation is unknown. These studies now report that silencing of Dbn1 inDCresulted in restrained cell surface display of receptors, most notablyMHCclass I andIIand co‐stimulatory molecules. This, as expected, resulted in impaired antigen‐specific T‐cell activation and proliferation. Studies additionally revealed that knockdown of Dbn1 inDCimpaired macropinocytosis and phagocytosis. However, there was a concomitant increase in fluid‐phase uptake, suggesting that Dbn1 is responsible for the differential control of macropinocytosis versus micropinocytosis activities. Taken together, these findings now reveal that Dbn1 plays a major role in coordinating the actin cytoskeletal activities responsible for antigen presentation inDC.

     
    more » « less
  4. Summary

    B‐cell responses are dynamic processes that depend on multiple types of interactions. Rare antigen‐specific B cells must encounter antigen and specialized systems are needed—unique to each lymphoid tissue type—to ensure this happens efficiently. Lymphoid tissue barrier cells act to ensure that pathogens, while being permitted entry for B‐cell recognition, are blocked from replication or dissemination. T follicular helper (Tfh) cells often need to be primed by dendritic cells before supporting B‐cell responses. For most responses, antigen‐specific helper T cells and B cells need to interact, first to initiate clonal expansion and the plasmablast response, and later to support the germinal center (GC) response. Newly formed plasma cells need to travel to supportive niches.GCB cells must become confined to the follicle center, organize into dark and light zones, and interact with Tfh cells. Memory B cells need to be positioned for rapid responses following reinfection. Each of these events requires the actions of multiple G‐protein coupled receptors (GPCRs) and their ligands, including chemokines and lipid mediators. This review will focus on the guidance cue code underlying B‐cell immunity, with an emphasis on findings from our laboratory and on newer advances in related areas. We will discuss our recent identification of geranylgeranyl‐glutathione as a ligand for P2RY8. Our goal is to provide the reader with a focused knowledge about theGPCRs guiding B‐cell responses and how they might be therapeutic targets, while also providing examples of how multiple types ofGPCRs can cooperate or act iteratively to control cell behavior.

     
    more » « less
  5. Summary

    Here we report the expression of programmed cell death ligand 1/2 (PD‐L1/L2) in breast and colon cancer stem cells (CSCs). The stemness of these cells was confirmed by their surface markers. Using flow cytometry analysis we demonstrated thatPD‐L1 expression was higher inCSCs of both cancers compared to non‐stem like cancer cells. Consistent with this, detection of cellularPD‐L1 proteins by western blot assay also showed increasedPD‐L1 protein inCSCs. In contrast, only trace amounts ofPD‐L2 were detected inCSCs of both cancers. Our results suggest that breast and colon cancers may be sensitive toPD1/PD‐L1 immunotherapy and thus warrant further investigations ofCSCtargetedPD1/PD‐L1 therapy.

     
    more » « less